Evaluation of hepatic vessels by transesophageal echocardiography during living donor liver transplantation.
Not Applicable
- Conditions
- Health Condition 1: K740- Hepatic fibrosis
- Registration Number
- CTRI/2021/10/037235
- Lead Sponsor
- Dr Swati Gupta
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
All patients undergoing living donor liver transplantation
Exclusion Criteria
1. Previous history of esophageal pathology like stricture, malignancy, diverticulum, laceration or history of previous esophageal surgery.
2. Esophageal varices > grade 2, gastric varices or active esophagitis.
4. History of recent upper gastro-intestinal bleed (within 1 month).
5. History of variceal banding within last month
5. Patient not willing to provide informed consent.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie hepatic vascular changes detected by TEE in patients with K740 fibrosis undergoing LDLT?
How effective is TEE compared to intraoperative Doppler ultrasound in assessing hepatic vessel patency during LDLT?
Which biomarkers predict successful hepatic vessel anastomosis in LDLT when evaluated by TEE?
What adverse events related to hepatic vasculature are identified by TEE during LDLT and how are they managed?
What alternative imaging technologies are used for real-time hepatic vessel assessment in LDLT besides TEE?